<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transfusion of blood products may be followed by <z:hpo ids='HP_0006562'>viral hepatitis</z:hpo> and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> despite improved techniques for prevention </plain></SENT>
<SENT sid="1" pm="."><plain>In view of the need for intensive therapy of <z:e sem="disease" ids="C0684275,C0019069" disease_type="Disease or Syndrome" abbrv="">hemophilia</z:e> with blood products, the authors investigated the capacity of these concentrates to influence cultures of human bone marrow cells </plain></SENT>
<SENT sid="2" pm="."><plain>Factor VIII concentrates contained a heat-stable dialyzable substance(s) that drastically impaired 59Fe incorporation in <z:mpath ids='MPATH_458'>normal</z:mpath> human bone marrow </plain></SENT>
<SENT sid="3" pm="."><plain>Factor IX concentrates had less and cryoprecipitate had no such inhibitory activity </plain></SENT>
<SENT sid="4" pm="."><plain>These studies may offer information regarding the effects of various blood products on bone marrow function </plain></SENT>
</text></document>